Quell Therapeutics secures $40M in a series A extension.
10 February 2021
10 February 2021
Total investments received (USD): 266.17m
Company: Quell Therapeutics
Related deals
SolasCure raised £15M series A
Investments
02 August 2021
Mestag Therapeutics extends seed financing to $45 million backed by Forbion, GV and Northpond Ventures
Investments
01 August 2021
Leo Cancer Care raised $25.3M series B with Pureland Venture Global
Investments
25 July 2021
PhoreMost raised £33M series B with BGF et al
Investments
11 May 2021
NeoPhore raised £15.2M
Investments
24 March 2021
Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Spain